| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/14787210.2017.1272411 |
| P698 | PubMed publication ID | 27973923 |
| P50 | author | Holger W Unger | Q91413738 |
| P2093 | author name string | Stephen J Rogerson | |
| P2860 | cites work | Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review | Q21133667 |
| Intermittent presumptive treatment for malaria | Q24809091 | ||
| Maternal malaria and gravidity interact to modify infant susceptibility to malaria | Q24814453 | ||
| Prevalence of malaria infection in pregnant women compared with children for tracking malaria transmission in sub-Saharan Africa: a systematic review and meta-analysis | Q26795709 | ||
| Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis | Q26849714 | ||
| Declining malaria in Africa: improving the measurement of progress | Q26863781 | ||
| In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin | Q27861946 | ||
| Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria | Q27976511 | ||
| Review of mass drug administration for malaria and its operational challenges | Q28083426 | ||
| The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015 | Q28267425 | ||
| The APPLe study: a randomized, community-based, placebo-controlled trial of azithromycin for the prevention of preterm birth, with meta-analysis | Q28471972 | ||
| Safety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trial | Q28538874 | ||
| Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial | Q28543146 | ||
| Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial | Q28543154 | ||
| Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model | Q28550515 | ||
| Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized [...] | Q28554025 | ||
| Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009-11. | Q30668656 | ||
| Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review | Q33288230 | ||
| Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic | Q33328938 | ||
| Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study | Q33528929 | ||
| Malaria prevention with IPTp during pregnancy reduces neonatal mortality | Q33535850 | ||
| Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial | Q33784329 | ||
| A research agenda for malaria eradication: diagnoses and diagnostics | Q33818031 | ||
| Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro | Q34111879 | ||
| Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations | Q34134036 | ||
| Prioritizing pregnant women for long-lasting insecticide treated nets through antenatal care clinics | Q34155202 | ||
| Malaria in pregnancy in the Asia-Pacific region | Q34242348 | ||
| Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial | Q34341776 | ||
| Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda | Q34359439 | ||
| Malaria and HIV infection in Mozambican pregnant women are associated with reduced transfer of antimalarial antibodies to their newborns | Q34441166 | ||
| Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa | Q34509542 | ||
| Four Artemisinin-Based Treatments in African Pregnant Women with Malaria | Q34517634 | ||
| Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial | Q35008674 | ||
| Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults | Q35190340 | ||
| Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance | Q35452357 | ||
| Malaria preventive therapy in pregnancy and its potential impact on immunity to malaria in an area of declining transmission | Q35666958 | ||
| Malaria and immunity during pregnancy and postpartum: a tale of two species | Q35678578 | ||
| Global Call to Action: maximize the public health impact of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa. | Q35689995 | ||
| Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial | Q38904423 | ||
| Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine | Q38920997 | ||
| Azithromycin-containing intermittent preventive treatment in pregnancy affects gestational weight gain, an important predictor of birthweight in Papua New Guinea - an exploratory analysis | Q38963583 | ||
| Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1. | Q39214852 | ||
| Mefloquine at the crossroads? Implications for malaria chemoprophylaxis in Europe | Q39219715 | ||
| Malaria in pregnancy: challenges for control and the need for urgent action | Q39245562 | ||
| Effects of Plasmodium vivax malaria in pregnancy | Q39309842 | ||
| Decreasing malaria prevalence and its potential consequences for immunity in pregnant women | Q39517373 | ||
| Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study. | Q39569746 | ||
| Return of chloroquine antimalarial efficacy in Malawi. | Q40465221 | ||
| Changing Trends in P. falciparum Burden, Immunity, and Disease in Pregnancy | Q40942459 | ||
| Use of macrolides during pregnancy and the risk of birth defects: a population-based study | Q41172176 | ||
| Malaria chemoprophylaxis regimens: a descriptive drug utilization study | Q41921066 | ||
| Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial | Q41943572 | ||
| Bed nets for the prevention of malaria and anaemia in pregnancy | Q46365244 | ||
| The effect of antenatal monthly sulphadoxine-pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial. | Q46571385 | ||
| Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials | Q47844653 | ||
| A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy | Q35741292 | ||
| Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women | Q35746240 | ||
| High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission | Q35867607 | ||
| The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients | Q35906361 | ||
| Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study | Q35942403 | ||
| User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya | Q35960893 | ||
| The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women | Q35965229 | ||
| Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial | Q36057593 | ||
| Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria | Q36125476 | ||
| Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults | Q36300127 | ||
| Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an op | Q36478633 | ||
| Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight | Q36603993 | ||
| Influence of Intermittent Preventive Treatment on Antibodies to VAR2CSA in Pregnant Cameroonian Women | Q36644516 | ||
| Epidemiology and burden of malaria in pregnancy | Q36717617 | ||
| Malaria in pregnancy: pathogenesis and immunity | Q36717621 | ||
| Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study | Q36809595 | ||
| Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy | Q36843561 | ||
| Metagenomic Analysis of Antibiotic-Induced Changes in Gut Microbiota in a Pregnant Rat Model | Q36848257 | ||
| Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation? | Q36981470 | ||
| Safety, tolerability and pharmacokinetic properties of coadministered azithromycin and piperaquine in pregnant Papua New Guinean women | Q37030663 | ||
| Ownership and use of insecticide-treated nets during pregnancy in sub-Saharan Africa: a review | Q37071867 | ||
| Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment | Q37211417 | ||
| Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, Tanzania | Q37262379 | ||
| Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting | Q37496851 | ||
| On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections | Q37530197 | ||
| Perceptions of malaria in pregnancy and acceptability of preventive interventions among Mozambican pregnant women: implications for effectiveness of malaria control in pregnancy | Q37548377 | ||
| Preliminary study of quinine pharmacokinetics in pregnant women with malaria-HIV co-infection | Q37623297 | ||
| Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa | Q38045143 | ||
| Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria | Q38136762 | ||
| Burden of malaria in early pregnancy: a neglected problem? | Q38264242 | ||
| A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana | Q38387621 | ||
| Insecticide Resistance in African Anopheles Mosquitoes: A Worsening Situation that Needs Urgent Action to Maintain Malaria Control | Q38716740 | ||
| Treatment regimens for pregnant women with falciparum malaria | Q38870452 | ||
| P433 | issue | 4 | |
| P921 | main subject | pregnancy-associated malaria | Q7239883 |
| malaria | Q12156 | ||
| malaria prevention | Q93598033 | ||
| P304 | page(s) | 361-375 | |
| P577 | publication date | 2016-12-15 | |
| P1433 | published in | Expert Review of Anti-infective Therapy | Q15734432 |
| P1476 | title | Prevention and control of malaria in pregnancy - new threats, new opportunities? | |
| P478 | volume | 15 |
| Q51731389 | 'Researchers have love for life': opportunities and barriers to engage pregnant women in malaria research in post-Ebola Liberia. |
| Q92575648 | A Randomized Open-Label Evaluation of the Antimalarial Prophylactic Efficacy of Azithromycin-Piperaquine versus Sulfadoxine-Pyrimethamine in Pregnant Papua New Guinean Women |
| Q47797899 | Management of malaria in pregnancy |
| Q64258389 | Sulphadoxine-pyrimethamine plus azithromycin may improve birth outcomes through impacts on inflammation and placental angiogenesis independent of malarial infection |
| Q90177221 | [Sulfadoxine-pyrimethamine-based intermittent preventive treatment in pregnant women and its effect on birth weight: application of 3-dosing regimen in the urban area of South Benin in 2017] |
Search more.